Literature DB >> 10690931

Characterisation of monoclonal antibodies to ovine interleukin-6 and the development of a sensitive capture ELISA.

P McWaters1, L Hurst, P J Chaplin, R A Collins, P R Wood, J P Scheerlinck.   

Abstract

A purified recombinant ovine (rOv) interleukin-6 (IL-6) was used to generate specific murine monoclonal antibodies (mAbs) and a polyclonal rabbit antisera to this cytokine. From the 31 initial hybridoma cell lines generated, three stable clones were established which secreted mAbs to rOvIL-6, as judged by a direct enzyme-linked immunosorbent assay (ELISA) and Western blotting. Their specificity was further confirmed by demonstrating that none of the mAbs recognised any of the six other irrelevant recombinant ovine cytokines tested by direct ELISA. All three mAbs displayed cross-reactivity with human and African green monkey IL-6 as demonstrated by direct ELISA and Western blotting. In contrast, the polyclonal antibodies only cross-reacted with bovine IL-6 and not with either of the human or monkey homologues. By combining a mAb with the polyclonal antisera a sensitive, IL-6-specific, capture ELISA was developed that had a sensitivity of 150 pg/ml. This detection system was unequivocally validated by demonstrating that native OvIL-6 could be detected in efferent lymph draining from a stimulated popliteal lymph node. In addition, one of the mAbs was shown to allow the detection of OvIL-6 by intracellular cytokine staining and flow cytometry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690931     DOI: 10.1016/s0165-2427(99)00158-0

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Pregnancy-associated genes contribute to antiluteolytic mechanisms in ovine corpus luteum.

Authors:  Jared J Romero; Alfredo Q Antoniazzi; Natalia P Smirnova; Brett T Webb; Fang Yu; John S Davis; Thomas R Hansen
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

2.  Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.

Authors:  Jiyong Zhang; Grazyna B Sadowska; Xiaodi Chen; Seon Yeong Park; Jeong-Eun Kim; Courtney A Bodge; Erin Cummings; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; William A Banks; Barbara S Stonestreet
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

3.  In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.

Authors:  X Chen; S W Threlkeld; E E Cummings; G B Sadowska; Y-P Lim; J F Padbury; S Sharma; B S Stonestreet
Journal:  J Comp Pathol       Date:  2012-07-20       Impact factor: 1.311

4.  Ovine proinflammatory cytokines cross the murine blood-brain barrier by a common saturable transport mechanism.

Authors:  Steven W Threlkeld; Jessica L Lynch; Kristin M Lynch; Grazyna B Sadowska; William A Banks; Barbara S Stonestreet
Journal:  Neuroimmunomodulation       Date:  2010-05-28       Impact factor: 2.492

5.  A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.

Authors:  Lena Wester-Rosenlöf; Vera Casslén; Josefin Axelsson; Anneli Edström-Hägerwall; Magnus Gram; Madlene Holmqvist; Martin E Johansson; Iréne Larsson; David Ley; Karel Marsal; Matthias Mörgelin; Bengt Rippe; Sigurbjörg Rutardottir; Behnaz Shohani; Bo Akerström; Stefan R Hansson
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Modulation of the transcription factor NF-κB in antigen-presenting cells by bovine respiratory syncytial virus small hydrophobic protein.

Authors:  Nicola Pollock; Geraldine Taylor; Fatoumatta Jobe; Efrain Guzman
Journal:  J Gen Virol       Date:  2017-07-17       Impact factor: 3.891

Review 7.  Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period.

Authors:  Clémence Disdier; Xiaodi Chen; Jeong-Eun Kim; Steven W Threlkeld; Barbara S Stonestreet
Journal:  Brain Sci       Date:  2018-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.